|
Research and Development |
|
Matriks Biotechnology produces, ELISA kits for estimating biopharmaceutical drug levels, such as humanized monoclonal antibodies used for treatment of several diseases and monoclonal antibodies and recombinant proteins.
Focused on new products, Matriks Biotechnology is consistently in the endeavour of adding new products to its pipeline.
Major areas of interest are as follows.
¨ Biotherapeutics and novel markers for diseases ¨ Obesity, type II diabetes and cardiovascular diease ¨ Inflammation and Immunology ¨ Apoptosis ¨ Infectious diseases ¨ Vaccines ¨ Oncology
|
